ALZpath, Inc.-preview

Alzpath

ALZpath, Inc.

Private

Carlsbad, CaliforniaHealthcare & Life Scienceshttps://alzpath.bio/

Last Round

Seed

Jul 18, 2023

Total Funding Raised

$1.9M

Momentum Score

25 /100

Company Overview

ALZpath, Inc. is a biotechnology company that develops diagnostic tools and solutions for Alzheimer's disease, centered around its proprietary pTau217 antibody for blood-based testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

Alzheimer's diagnosticspTau217 antibodypTau217Alzheimer's blood testdiagnostic antibodyAlzheimer's biomarkerantibody licensingnon-invasive diagnosticsimmunoassayin-vitro diagnosticsIVDneurodiagnosticslaboratory developed testLDT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ALZpath, Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ALZpath, Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jul 18, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Mike Banville

Chief Executive Officer

Executive Team

ALZpath, Inc. Investors

Notable investors and investment history

Investor	Rounds
StartUp Health	Seed
Stead Impact Ventures and Foundation	Seed
Alzheimer's Drug Discovery Foundation	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 22, 2026
Monthly visitors increased 133% MoM, reaching 3.5K.
Jan 5, 2026
Monthly visitors increased 75% MoM.

View all signals

ALZpath, Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ALZpath, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ALZpath, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCarlsbad, California

Employee Range10

Year Founded2020

Last FundingJul 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.